(Q38077820)

28 August 2017

1 reference

title

Primary sclerosing cholangitis: a review and update on therapeutic developments (English)

1 reference

primary sclerosing cholangitis

28 August 2017

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

1 reference

James H Tabibian

1

1 reference

PubMed ID

23363260

28 August 2017

Keith D Lindor

series ordinal

2

1 reference

28 August 2017

1 February 2013

1 reference

Expert Review of Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

7

1 reference

28 August 2017

2

1 reference

28 August 2017

103-114

1 reference

The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.

28 August 2017

1 reference

Pathogenesis of primary sclerosing cholangitis.

21 January 2018

1 reference

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

21 January 2018

1 reference

Cancer surveillance in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

21 January 2018

1 reference

Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased?

21 January 2018

1 reference

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass

21 January 2018

1 reference

IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.

21 January 2018

1 reference

New treatment strategies for primary sclerosing cholangitis

21 January 2018

1 reference

Autoimmune pancreatitis: an update on classification, diagnosis, natural history and management

21 January 2018

1 reference

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

21 January 2018

1 reference

Pirfenidone in the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study

21 January 2018

1 reference

Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study

21 January 2018

1 reference

Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid

21 January 2018

1 reference

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

21 January 2018

1 reference

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

21 January 2018

1 reference

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

21 January 2018

1 reference

Antibiotics for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease

21 January 2018

1 reference

Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic

21 January 2018

1 reference

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

21 January 2018

1 reference

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

21 January 2018

1 reference

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation

21 January 2018

1 reference

COX-2: a molecular target for colorectal cancer prevention

21 January 2018

1 reference

21 January 2018

1 reference

NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection

21 January 2018

1 reference

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

21 January 2018

1 reference

Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression

21 January 2018

1 reference

Fueling fibrosis in chronic hepatitis C.

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

Etiopathogenesis of primary sclerosing cholangitis

21 January 2018

1 reference

Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

21 January 2018

1 reference

Portal bacteraemia in cases of ulcerative colitis submitted to colectomy.

21 January 2018

1 reference

Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A

21 January 2018

1 reference

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.

21 January 2018

1 reference

Will we ever model PSC? - "it's hard to be a PSC model!".

21 January 2018

1 reference

Gut homing receptors on CD8 T cells are retinoic acid dependent and not maintained by liver dendritic or stellate cells.

21 January 2018

1 reference

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

21 January 2018

1 reference

Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders

21 January 2018

1 reference

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

21 January 2018

1 reference

The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood

21 January 2018

1 reference

The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults

21 January 2018

1 reference

The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females.

21 January 2018

1 reference

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice

21 January 2018

1 reference

Molecular targets for the treatment of fibrosing cholangiopathies

21 January 2018

1 reference

Cordycepin as a sensitizer to tumour necrosis factor (TNF)-α-induced apoptosis through eukaryotic translation initiation factor 2α (eIF2α)- and mammalian target of rapamycin complex 1 (mTORC1)-mediated inhibition of nuclear factor (NF)-κB.

21 January 2018

1 reference

Rapamycin sensitizes Akt inhibition in malignant human breast epithelial cells

21 January 2018

1 reference

Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma

21 January 2018

1 reference

Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis.

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

21 January 2018

1 reference

The role of the renin-angiotensin system in liver fibrosis

21 January 2018

1 reference

Liver fibrogenesis: a new role for the renin-angiotensin system

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

21 January 2018

1 reference

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.

21 January 2018

1 reference

Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver

21 January 2018

1 reference

Nuclear receptors as therapeutic targets in cholestatic liver diseases.

21 January 2018

1 reference

Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease

21 January 2018

1 reference

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease

21 January 2018

1 reference

Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis

21 January 2018

1 reference

Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography

21 January 2018

1 reference

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

21 January 2018

1 reference

Elastography for detecting hepatic fibrosis: options and considerations

21 January 2018

1 reference

Current topics in pancreato-biliary endotherapy: what can we do?

21 January 2018

1 reference

Inflammatory bowel disease-associated thromboembolism: a systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis

21 January 2018

1 reference

Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model.

21 January 2018

1 reference

Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.

21 January 2018

1 reference

Designer stents: are we there yet?

21 January 2018

1 reference

Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures

21 January 2018

1 reference

Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video).

21 January 2018

1 reference

Four years experience with short term stenting in primary sclerosing cholangitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.12.80

1 reference

28 August 2017

1 reference

PubMed ID

23363260